US News

Pfizer-BioNTech to seek authorization for 3rd Covid shot: statement

Published by
AFP

Washington (AFP) – Pfizer and BioNTech announced Thursday they would seek regulatory authorization for a third dose of their Covid-19 vaccine. It comes after initial data from an ongoing trial showed a third shot pushed antibody levels five to 10 times higher against the original coronavirus strain and the Beta variant, first found in South Africa, compared to the first two doses alone, according to a statement. “The companies expect to publish more definitive data soon as well as in a peer-reviewed journal and plan to submit the data to the FDA (Food and Drug Administration), EMA (European Me…

Read More

Facebook Comments

Check Also

How to help older people have fun online, step by step

Published by DPA It can be scary for ...

Archives